TY - JOUR
T1 - Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient
AU - Tacke, Frank
AU - Amini-Bavil-Olyaee, Samad
AU - Heim, Albert
AU - Luedde, Tom
AU - Manns, Michael P.
AU - Trautwein, Christian
N1 - Funding Information:
This work was supported by the German network of competence for viral hepatitis (‘Hep-Net’), the EU grant of Virgil (to C.T. and F.T.) and the START-Program of the Faculty of Medicine, RWTH Aachen (to F.T.). The authors declare that they have no conflict of interests.
PY - 2007/4
Y1 - 2007/4
N2 - Background: : Hepatitis B Virus (HBV) infection is a leading cause of chronic hepatitis and liver cirrhosis worldwide, and efficient protection can usually be achieved by vaccination that is based on recombinant HBsAg protein from HBV genotype A and D. Results: : Here we report the case of a fully immune-competent German patient that acquired a symptomatic acute HBV infection during adulthood despite a complete and formally successful vaccination, which had resulted in anti-HBs titers considered protective. Further phylogentic analysis identified an infection with the rare genotype F of HBV, possibly acquired in Spain, without apparent aberrations in the immunodominant 'a' determinant domain of the envelope gene. However, sequence comparisons revealed that all reported genotype F isolates display marked differences from the other genotypes in this domain which serves as an epitope for humoral immune responses. Conclusions: : The rare HBV genotype F, as detected in this immune-competent, previously vaccinated patient, has marked sequences differences in the envelope/polymerase gene. Therefore, current HBV vaccines based on genotype A and D may not result in full protective immunity towards viral strains from genotype F.
AB - Background: : Hepatitis B Virus (HBV) infection is a leading cause of chronic hepatitis and liver cirrhosis worldwide, and efficient protection can usually be achieved by vaccination that is based on recombinant HBsAg protein from HBV genotype A and D. Results: : Here we report the case of a fully immune-competent German patient that acquired a symptomatic acute HBV infection during adulthood despite a complete and formally successful vaccination, which had resulted in anti-HBs titers considered protective. Further phylogentic analysis identified an infection with the rare genotype F of HBV, possibly acquired in Spain, without apparent aberrations in the immunodominant 'a' determinant domain of the envelope gene. However, sequence comparisons revealed that all reported genotype F isolates display marked differences from the other genotypes in this domain which serves as an epitope for humoral immune responses. Conclusions: : The rare HBV genotype F, as detected in this immune-competent, previously vaccinated patient, has marked sequences differences in the envelope/polymerase gene. Therefore, current HBV vaccines based on genotype A and D may not result in full protective immunity towards viral strains from genotype F.
KW - A-determinant region
KW - Antigenicity
KW - Escape mutant
KW - Genotype
KW - HBV DNA
KW - Hepatitis B Virus
UR - https://www.scopus.com/pages/publications/33947127750
U2 - 10.1016/j.jcv.2006.12.024
DO - 10.1016/j.jcv.2006.12.024
M3 - Article
C2 - 17324621
AN - SCOPUS:33947127750
SN - 1386-6532
VL - 38
SP - 353
EP - 357
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
IS - 4
ER -